2.150USD+0.47%Mkt Cap: 84.65M USDP/E: —Last update: 2026-06-01
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM t…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap84.65M USD
Enterprise Value39.69M USD
Revenue (TTM)57.00K USD
Gross Profit-83.00K USD
Net Income (TTM)-31.93M USD
Revenue/Share0.0010 USD
Last Price2.150 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees71
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.15
PEG—
EV/EBITDA-1.11
EV/Revenue696.26
P/S1483.91
P/B1.12
EPS (TTM)-0.64
EPS (Forward)-0.69
52W Range
1.37029% of range4.090
52W High4.090 USD
52W Low1.370 USD
Profitability
Gross Margin-102.47%
Oper. Margin-66857.14%
EBITDA Margin0.00%
Profit Margin-39417.28%
ROE-42.34%
ROA-31.32%
Growth
Revenue Growth-63.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.62M USD
CapEx (TTM)726.00K USD
FCF Margin-33163.38%
FCF Yield-22.33%
Net Debt-44.90M USD
Net Debt/EBITDA1.25
Balance Sheet
Debt/Equity0.03
Current Ratio2.12
Quick Ratio2.02
Book Value/Sh1.936 USD
Cash/Share1.210 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.000 USD
Target Range5.000 USD – 5.000 USD
# Analysts1
Ownership
Shares Out.38.19M
Float27.58M
Insiders11.68%
Institutions63.14%
Short Interest
Short Ratio7.0d
Short % Float0.91%
Short % Out.0.72%
Shares Short280.98K
Short (prev mo.)347.82K
Technical
SMA 501.988 (+8.2%)
SMA 2002.727 (-21.2%)
Beta0.93
S&P 52W Chg27.70%
Avg Vol (30d)58.05K
Avg Vol (10d)95.70K
Technical Indicators
RSI (14)59.9
MACD0.0220
MACD Signal-0.0327
MACD Hist.+0.0546
BB Upper2.204 USD
BB Middle1.872 USD
BB Lower1.540 USD
BB Width35.45%
ATR (14)0.2206 USD
Vol Ratio (20d)0.34x